Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο:
https://hdl.handle.net/10442/19431
Εξειδίκευση τύπου : | Άρθρο σε επιστημονικό περιοδικό |
Τίτλος: | Fabricating Polymer/Surfactant/Cyclodextrin Hybrid Particles for Possible Nose-to-Brain Delivery of Ropinirole Hydrochloride: In Vitro and Ex Vivo Evaluation |
Δημιουργός/Συγγραφέας: | Saitani, Elmina-Marina Pippa, Natassa Perinelli, Diego Romano Forys, Aleksander Papakyriakopoulou, Paraskevi Lagopati, Nefeli Bonacucina, Giulia Trzebicka, Barbara Gazouli, Maria [EL] Πίσπας, Στέργιος[EN] Pispas, Stergios Valsami, Georgia |
Ημερομηνία: | 2024-01-18 |
Γλώσσα: | Αγγλικά |
ISSN: | 1422-0067 |
DOI: | 10.3390/ijms25021162 |
Άλλο: | 38256239 |
Περίληψη: | Ropinirole is a non-ergolinic dopamine agonist used to manage Parkinson's disease and it is characterized by poor oral bioavailability. This study aimed to design and develop advanced drug delivery systems composed of poloxamer 407, a non-ionic surfactant (Tween 80), and cyclodextrins (methyl-β-CD or hydroxy-propyl-β-CD) for possible brain targeting of ropinirole after nasal administration for the treatment of Parkinson's disease. The hybrid systems were formed by the thin-film hydration method, followed by an extensive physicochemical and morphological characterization. The in vitro cytotoxicity of the systems on HEK293 cell lines was also tested. In vitro release and ex vivo mucosal permeation of ropinirole were assessed using Franz cells at 34 °C and with phosphate buffer solution at pH 5.6 in the donor compartment, simulating the conditions of the nasal cavity. The results indicated that the diffusion-controlled drug release exhibited a progressive increase throughout the experiment, while a proof-of-concept experiment on ex vivo permeation through rabbit nasal mucosa revealed a better performance of the prepared hybrid systems in comparison to ropinirole solution. The encouraging results in drug release and mucosal permeation indicate that these hybrid systems can serve as attractive platforms for effective and targeted nose-to-brain delivery of ropinirole with a possible application in Parkinson's disease. Further ex vivo and in vivo studies to support the results of the present work are ongoing. |
Τίτλος πηγής δημοσίευσης: | International journal of molecular sciences |
Τόμος/Κεφάλαιο: | 25 |
Τεύχος: | 2 |
Θεματική Κατηγορία: | [EL] Φαρμακευτική τεχνολογία[EN] Pharmaceutical technology [EL] Νανοτεχνολογία[EN] Nanotechnology [EL] Θεραπευτική. Φαρμακολογία[EN] Therapeutics.Pharmacology [EL] Φυσική και θεωρητική χημεία[EN] Physical and theoretical chemistry |
Λέξεις-Κλειδιά: | Franz type diffusion cells cryo-TEM images cyclodextrins ex vivo nasal permeability nose-to-brain transport poloxamer 407 ropinirole hydrochloride surfactant |
Κάτοχος πνευματικών δικαιωμάτων: | © 2024 by the authors. Licensee MDPI, Basel, Switzerland. |
Όροι και προϋποθέσεις δικαιωμάτων: | This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). |
Ηλεκτρονική διεύθυνση στον εκδότη (link): | https://doi.org/10.3390/ijms25021162 |
Εμφανίζεται στις συλλογές: | Ινστιτούτο Θεωρητικής και Φυσικής Χημείας (ΙΘΦΧ) - Επιστημονικό έργο
|